Azido Inositol Probes Enable Metabolic Labeling of Inositol-Containing Glycans and Reveal an Inositol Importer in Mycobacteria
ACS Chemical Biology · 2023
DOI: 10.1021/acschembio.2c00912 ↗At a glance
Journal article in ACS Chemical Biology, 2023. Written by Heather Hodges and 8 co-authors. Institution: Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523 Uni…. Major MEDLINE topics: Mycobacterium, Mycobacterium tuberculosis. Cited 7 times so far (Crossref); 59 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (original language)
Bacteria from the genus Mycobacterium include pathogens that cause serious diseases in humans and remain as difficult infectious agents to treat. Central to these challenges are the composition and organization of the mycobacterial cell envelope, which includes unique and complex glycans. Inositol is an essential metabolite for mycobacteria due to its presence in the structural core of the immunomodulatory cell envelope glycolipids phosphatidylinositol mannoside (PIM) and PIM-anchored lipomannan (LM) and lipoarabinomannan (LAM). Despite their importance to mycobacterial physiology and pathogenesis, many aspects of PIM, LM, and LAM construction and dynamics remain poorly understood. Recently, probes that allow metabolic labeling and detection of specific mycobacterial glycans have been developed to investigate cell envelope assembly and dynamics. However, these tools have been limited to peptidoglycan, arabinogalactan, and mycolic acid-containing glycolipids. Herein, we report the development of synthetic azido inositol (InoAz) analogues as probes that can metabolically label PIMs, LM, and LAM in intact mycobacteria. Additionally, we leverage an InoAz probe to discover an inositol importer and catabolic pathway in Mycobacterium smegmatis. We anticipate that in the future, InoAz probes, in combination with bioorthogonal chemistry, will provide a valuable tool for investigating PIM, LM, and LAM biosynthesis, transport, and dynamics in diverse mycobacterial organisms.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523 United States.
- Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859 United States.
- Biochemistry, Cellular, and Molecular Biology Program, Central Michigan University, Mount Pleasant, Michigan 48859 United States.
ORCID profiles: Mary Jackson
Funding
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Camille and Henry Dreyfus Foundation
- National Science Foundation
Cite
APA
Hodges, H., Obeng, K., Avanzi, C., Ausmus, A. P., Angala, S. K., Kalera, K., Palcekova, Z., Swarts, B. M., & Jackson, M. (2023). Azido Inositol Probes Enable Metabolic Labeling of Inositol-Containing Glycans and Reveal an Inositol Importer in Mycobacteria. ACS Chemical Biology. https://doi.org/10.1021/acschembio.2c00912
Vancouver
Hodges H, Obeng K, Avanzi C, Ausmus AP, Angala SK, Kalera K, et al. Azido Inositol Probes Enable Metabolic Labeling of Inositol-Containing Glycans and Reveal an Inositol Importer in Mycobacteria. ACS Chemical Biology. 2023. doi:10.1021/acschembio.2c00912
BibTeX
@article{Hodges2023,
author = {Hodges, Heather and Obeng, Kwaku and Avanzi, Charlotte and Ausmus, Alex P and Angala, Shiva Kumar and Kalera, Karishma and Palcekova, Zuzana and Swarts, Benjamin M and Jackson, Mary},
title = {Azido Inositol Probes Enable Metabolic Labeling of Inositol-Containing Glycans and Reveal an Inositol Importer in Mycobacteria},
journal = {ACS Chemical Biology},
year = {2023},
doi = {10.1021/acschembio.2c00912}
}
EUVIMED